New drug may help radiation hit liver tumors more precisely
NCT ID NCT07312292
Summary
This study is testing whether a drug called angiotensin II can help a liver cancer treatment work better. The drug is given right before a standard radiation treatment to try to direct more radiation to the tumor and less to healthy liver tissue. Researchers will enroll 15 adults with liver cancer to see if this approach is safe and improves treatment targeting.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LIVER CANCER, ADULT are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University Medical Center Utrecht
RECRUITINGUtrecht, Utrecht, 3584 CX, Netherlands
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.